123 related articles for article (PubMed ID: 35752957)
21. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
[TBL] [Abstract][Full Text] [Related]
22. [Local recurrence of the renal cell carcinoma in renal fossa after complete radical nephrectomy. What are the risk factors?].
Ormanov D; Kirilov S; Ianev K; Georgiev M; Simeonov P; Dimitrov P; Bonev K; Vasilev V; Mavrov Kh; Panchev P
Khirurgiia (Sofiia); 2008; (1-2):34-6. PubMed ID: 18983006
[TBL] [Abstract][Full Text] [Related]
23. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
[TBL] [Abstract][Full Text] [Related]
24. Partial nephrectomy for renal cell carcinoma with a normal opposite kidney.
Herr HW
Cancer; 1994 Jan; 73(1):160-2. PubMed ID: 8275418
[TBL] [Abstract][Full Text] [Related]
25. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
26. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
28. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.
MacLennan S; Imamura M; Lapitan MC; Omar MI; Lam TB; Hilvano-Cabungcal AM; Royle P; Stewart F; MacLennan G; MacLennan SJ; Dahm P; Canfield SE; McClinton S; Griffiths TR; Ljungberg B; N'Dow J; ;
Eur Urol; 2012 Dec; 62(6):1097-117. PubMed ID: 22841673
[TBL] [Abstract][Full Text] [Related]
29. Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma.
Uzzo RG; Wei JT; Hafez K; Kay R; Novick AC
Urology; 1999 Dec; 54(6):994-8. PubMed ID: 10604696
[TBL] [Abstract][Full Text] [Related]
30. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
31. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma.
Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ
Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919
[TBL] [Abstract][Full Text] [Related]
32. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up.
Somani BK; Nabi G; Thorpe P; N'Dow J; Swami S; McClinton S;
Eur Urol; 2007 May; 51(5):1289-95; discussion 1296-7. PubMed ID: 17081679
[TBL] [Abstract][Full Text] [Related]
33. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
34. Bilateral asynchronous renal cell carcinoma: treatment approach.
Kessler OJ; Livne PM; Servadio C
Isr J Med Sci; 1993 Nov; 29(11):721-5. PubMed ID: 8270406
[TBL] [Abstract][Full Text] [Related]
35. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy.
Breau RH; Crispen PL; Jimenez RE; Lohse CM; Blute ML; Leibovich BC
J Urol; 2010 Mar; 183(3):903-8. PubMed ID: 20083271
[TBL] [Abstract][Full Text] [Related]
36. Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy.
Lane BR; Fergany AF; Weight CJ; Campbell SC
J Urol; 2010 Oct; 184(4):1286-90. PubMed ID: 20723936
[TBL] [Abstract][Full Text] [Related]
37. The role of renal-sparing surgery for renal cell carcinoma.
Novick AC
Semin Urol; 1992 Feb; 10(1):12-5. PubMed ID: 1565898
[TBL] [Abstract][Full Text] [Related]
38. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
Adejoro O; Alishahi A; Konety B
Urology; 2016 Nov; 97():130-137.e1. PubMed ID: 27397095
[TBL] [Abstract][Full Text] [Related]
39. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
40. Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma.
Roos FC; Steffens S; Junker K; Janssen M; Becker F; Wegener G; Brenner W; Steinestel J; Schnoeller TJ; Schrader M; Hofmann R; Thüroff JW; Kuczyk MA; Wunderlich H; Siemer S; Hartmann A; Stöckle M; Schrader AJ;
BMC Cancer; 2014 May; 14():372. PubMed ID: 24885955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]